- Home
- IDXX vs TAK Comparison
IDXX vs TAK Comparison
Compare IDXX & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDXX
- TAK
- Stock Information
- Founded
- IDXX 1983
- TAK 1781
- Country
- IDXX United States
- TAK Japan
- Employees
- IDXX N/A
- TAK N/A
- Industry
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- IDXX Health Care
- TAK Health Care
- Exchange
- IDXX Nasdaq
- TAK Nasdaq
- Market Cap
- IDXX 37.9B
- TAK 45.8B
- IPO Year
- IDXX 1991
- TAK N/A
- Fundamental
- Price
- IDXX $525.83
- TAK $14.97
- Analyst Decision
- IDXX Buy
- TAK
- Analyst Count
- IDXX 8
- TAK 0
- Target Price
- IDXX $536.00
- TAK N/A
- AVG Volume (30 Days)
- IDXX 619.9K
- TAK 2.2M
- Earning Date
- IDXX 05-01-2025
- TAK 05-08-2025
- Dividend Yield
- IDXX N/A
- TAK 3.94%
- EPS Growth
- IDXX 4.80
- TAK N/A
- EPS
- IDXX 10.82
- TAK 0.45
- Revenue
- IDXX $3,931,836,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- IDXX $8.17
- TAK $1.01
- Revenue Next Year
- IDXX $7.61
- TAK $1.04
- P/E Ratio
- IDXX $48.62
- TAK $64.59
- Revenue Growth
- IDXX 5.56
- TAK 7.45
- 52 Week Low
- IDXX $356.14
- TAK $12.58
- 52 Week High
- IDXX $530.60
- TAK $15.43
- Technical
- Relative Strength Index (RSI)
- IDXX 70.44
- TAK 57.90
- Support Level
- IDXX $504.56
- TAK $14.51
- Resistance Level
- IDXX $520.00
- TAK $15.08
- Average True Range (ATR)
- IDXX 10.62
- TAK 0.15
- MACD
- IDXX -1.79
- TAK 0.10
- Stochastic Oscillator
- IDXX 98.22
- TAK 92.07
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.